Literature DB >> 28589262

The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.

Daisuke Taniguchi1, Naoya Yamasaki2, Takuro Miyazaki2, Tomoshi Tsuchiya2, Keitaro Matsumoto2, Go Hatachi2, Tomoyuki Kakugawa3, Noriho Sakamoto3, Hiroshi Mukae3, Takeshi Nagayasu2.   

Abstract

PURPOSE: Several studies have reported that an acute exacerbation (AE) of idiopathic interstitial pneumonia (IIP) can occur after lung resection in patients with non-small cell lung cancer (NSCLC); however, the perioperative management strategy is controversial.
METHODS: The data of lung cancer patients at Nagasaki University Hospital from June 1994 to October 2013 were retrospectively reviewed.
RESULTS: Among all 1701 NSCLC patients who underwent lung resection, 59 (3.5%) had IIP. Five patients (8.5%) had an AE of IIP following lung resection, three (60%) of whom died in hospital. Univariate and multivariate analyses were performed to identify possible risk factors for AE. The univariate analyses identified LDH and the volume of blood loss as risk factors. The multivariate analysis identified no factors. The treatment for an AE included steroid pulse therapy and neutrophil elastase inhibitor therapy. Direct hemoperfusion with polymyxin B immobilized the fiber column and immunosuppressant therapy was attempted in some of the patients who did not respond to these treatments.
CONCLUSION: Patients with lung cancer and IIP have a higher risk of chest surgery and a poor prognosis. Very careful surgery and perioperative management are needed, because AEs are often difficult to AE predict.

Entities:  

Keywords:  Acute exacerbation; Interstitial pneumonia; Lung resection; Non-small cell lung cancer

Mesh:

Substances:

Year:  2017        PMID: 28589262     DOI: 10.1007/s00595-017-1551-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  33 in total

1.  Idiopathic pulmonary fibrosis--clinical presentation, outcome and baseline prognostic factors in a Portuguese cohort.

Authors:  F Soares Pires; P Caetano Mota; N Melo; D Costa; J M Jesus; R Cunha; S Guimarães; C Souto-Moura; A Morais
Journal:  Rev Port Pneumol       Date:  2012-07-20

2.  Mesenchymal stem cells attenuate ischemia-reperfusion injury after prolonged cold ischemia in a mouse model of lung transplantation: a preliminary study.

Authors:  Tatsuaki Watanabe; Yasushi Hoshikawa; Naoya Ishibashi; Hirotoshi Suzuki; Hirotsugu Notsuda; Yui Watanabe; Masafumi Noda; Masahiko Kanehira; Shinya Ohkouchi; Takashi Kondo; Yoshinori Okada
Journal:  Surg Today       Date:  2016-08-02       Impact factor: 2.549

3.  Lung cancer in patients with idiopathic pulmonary fibrosis.

Authors:  J Park; D S Kim; T S Shim; C M Lim; Y Koh; S D Lee; W S Kim; W D Kim; J S Lee; K S Song
Journal:  Eur Respir J       Date:  2001-06       Impact factor: 16.671

Review 4.  Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.

Authors:  Kentaro Iwata; Asako Doi; Goh Ohji; Hideaki Oka; Yuichiro Oba; Kohei Takimoto; Wataru Igarashi; David H Gremillion; Toshihiko Shimada
Journal:  Intern Med       Date:  2010-11-15       Impact factor: 1.271

5.  Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer.

Authors:  Yasushi Shintani; Mitsunori Ohta; Teruo Iwasaki; Naoki Ikeda; Emiko Tomita; Kunimitsu Kawahara; Yuko Ohno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

6.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.

Authors:  Takekazu Iwata; Shigetoshi Yoshida; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Tetsuzo Tagawa; Teruaki Mizobuchi; Satoshi Ota; Yukio Nakatani; Ichiro Yoshino
Journal:  Surg Today       Date:  2014-11-22       Impact factor: 2.549

7.  Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study.

Authors:  Susumu Sakamoto; Sakae Homma; Mingyon Mun; Takeshi Fujii; Atsuko Kurosaki; Kunihiko Yoshimura
Journal:  Intern Med       Date:  2011-01-15       Impact factor: 1.271

8.  Lung cancer associated with usual interstitial pneumonia.

Authors:  H Matsushita; S Tanaka; Y Saiki; M Hara; K Nakata; S Tanimura; J Banba
Journal:  Pathol Int       Date:  1995-12       Impact factor: 2.534

9.  Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy.

Authors:  Kazutoshi Isobe; Yoshinobu Hata; Susumu Sakamoto; Yujiro Takai; Kazutoshi Shibuya; Sakae Homma
Journal:  Respirology       Date:  2009-11-30       Impact factor: 6.424

10.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.

Authors:  Toshihiko Sato; Satoshi Teramukai; Haruhiko Kondo; Atsushi Watanabe; Masahito Ebina; Kazuma Kishi; Yoshitaka Fujii; Tetsuya Mitsudomi; Masahiro Yoshimura; Tomohiro Maniwa; Kenji Suzuki; Kazuhiko Kataoka; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

View more
  4 in total

1.  Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia.

Authors:  Masaki Tomita; Takanori Ayabe; Ryo Maeda; Kunihide Nakamura
Journal:  World J Oncol       Date:  2018-11-23

2.  Impact of concomitant idiopathic pulmonary fibrosis on prognosis in lung cancer patients: A meta-analysis.

Authors:  Haoyu Wang; Ruiyuan Yang; Jing Jin; Zhoufeng Wang; Weimin Li
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

3.  Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: a systematic review and meta-analysis.

Authors:  Xiaohu Hao; Jianqi Hao; Cong Chen; Haoning Peng; Jian Zhang; Qi Cao; Lunxu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

4.  Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection.

Authors:  Weipeng Shao; Jingjing Huang; Hongxiang Feng; Hongliang Sun; Yanhong Ren; Xiaowei Wang; Zhenrong Zhang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.